FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells

BMB Reports

Volumn 45, Issue 5, 2012, Pages 287-292

  Kim, Hey Ryun ^a   Heo, Youn Moo ^a   Jeong, Kyoung Il ^a   Kim, Yong Min ^a   Jang, Hae Lan ^a   Lee, Kwang Yeol ^b   Yeo, Chang Yeol ^c   Kim, Sung Hoon ^d   Lee, Hak Kyo ^d   Kim, Seung Ryul ^a   Kim, Eung Gook ^a   Choi, Joong Kook ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chonnam National University   (South Korea)

^c Ewha Womans University   (South Korea)

^d Hankyong National University   (South Korea)

Author keywords

Apoptosis; ATDC5 cells; Bcl xL; Bcl2 A1; FGF 2; TNF

Indexed keywords

BCL2 RELATED PROTEIN A1; BCL2-RELATED PROTEIN A1; BCL2L1 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR 2; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL PROLIFERATION; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; STEM CELL; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84863438103     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.5.287     Document Type: Article

References (25)

1. Glaser, R. L., Broman, K. W., Schulman, R. L., Eskenazi, B., Wyrobek, A. J. and Jabs, E. W. (2003) The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutation in sperm. Am. J. Hum. Genet. 73, 939-947.
2. Goriely, A., McVean, G. A., Rojmyr, M., Ingemarsson, B. and Wilkie, A. O. (2003) Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301, 643.
3. Feldman, B., Poueymirou, W., Papaioannou, V. E., DeChiara, T. M. and Goldfarb, M. (1995) Requirement of FGF-4 for postimplantation mouse development. Science 267, 246- 249.
4. Colvin, J. S., White, A. C., Pratt, S. J. and Ornitz, D. M. (2001) Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development 128, 2095.
5. McIntosh, I., Bellus, G. A. and Jab, E. W. (2000) The pleiotropic effects of fibroblast growth factor receptors in mammalian development. Cell Struct. Funct. 25, 85-96.
6. Pardo, O. E., Lesay, A., Arcaro, A., Lopes, R., Ng, B. L., Warne, P. H., McNeish, I. A., Tetley, T. D., Lemoine, N. R., Mehmet, H., Seckl, M. J. and Downward, J. (2003) Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol. Cell Biol. 23, 7600-7610.
7. Chia, S. L., Sawaji, Y., Burleigh, A., McLean, C., Inglis, J., Saklatvala, J. and Vincent, T. (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60, 2019-2027.
8. Makino, T., Jinnin, M., Muchemwa, F. C., Fukushima, S., Kogushi-Nishi, H., Moriya, C., Igata, T., Fujisawa, A., Johno, T. and Ihn, H. (2010) Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways. Br. J. Dermatol. 62, 717-723.
9. Sahni, M., Ambrosetti, D. C., Mansukhani, A., Gertner, R., Levy, D. and Basilico, C. (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13, 1361-1366.
10. Krejci, P., Salazar, L., Goodridge, H. S., Kashiwada, T. A., Schibler, M. J., Jelinkova, P., Thompson, L. M. and Wilcox, W. R. (2008) STAT1 and STAT3 do not participate in FGFmediated growth arrest in chondrocytes. J. Cell Sci. 121, 272-281.
11. Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59.
12. Lin, E. Y., Orlofsky, A., Berger, M. S. and Prystowsky, M. B. (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151, 1979-1988.
13. Karsan, A., Yee, E. and Harlan, J. M. (1996) Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271, 27201-27204.
14. Cross, A., Moots, R. J. and Edwards, S. (2008) The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood 111, 878-884.
15. Tare, B. S., Howard, D., Pound, J. C., Roach, H. I. and Oreffo, R. O. C. (2005) ATDC5: an ideal cell line for development of tissue engineering strategies aimed at cartilage generation. Eur. Cell. Mater. 10(Suppl 2), 22.
16. Im, Y. S., Shin, H. K., Kim, H. R., Jeong, S. H., Kim, S. R., Kim, Y. M., Lee, D. H., Jeon, S. H., Lee, H. W. and Choi, J. K. (2009) Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1. Mol. Cells 28, 119-124.
17. Reers, M., Smith, T. W. and Chen, L. B. (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 7, 4480-4486.
18. Shirane, M. and Nakayama, K. I. (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5, 28-37.
19. Choi, B. H., Feng, L. and Yoon, H. S. (2010) FKBP38 protects Bcl-2 from caspase-dependent degradation. J. Biol. Chem. 285, 9770-9779.
20. Fiebig, A. A., Zhu, W., Hollerbach, C., Leber, B. and Andrews, D. W. (2006) Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer 6, 213.
21. Vogler, M., Dickens, D., Dyer, M. J., Owen, A., Pirmohamed M. and Cohen G. M. (2011) The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochem. Biophys. Res. Commun. 408, 344-349.
22. Lee, H. H., Dempsey, P. W., Parks, T. P., Zhu, X., Baltimore, D. and Cheng, G. (1999) Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NFkappaB activation and intercellular adhesion molecule-1 up-regulation. Proc. Natl. Acad. Sci. U.S.A 96, 1421-1426.
23. Duriez, P. J., Wong, F., Dorovini-Zis, K., Shahidi, R. and Karsan, A. (2000) A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J. Biol. Chem. 275, 18099-18107.
24. Wang, C. Y., Guttridge, D. C., Mayo, M. W. and Baldwin, A. S. Jr. (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell Biol. 19, 5923-5929.
25. Rastegar, F., Gao, J. L., Shenag, D., Luo, Q., Shi, Q., Kim, S. H., Jiang, W., Wagner, E. R., Huang, E., Gao, Y., Shen, J., Yang, K., He, B. C., Chen, L., Zuo, G. W., Luo, G. W., Luo, J., Luo, X., Bi, Y., Liu, X., Li, M., Hu, N., Wang, L., Luther, G., Luu, H. H., Haydon, R. C. and He, T. C. (2010) Lysophosphatidic acid acyltransferase β (LPAATβ) promotes the tumor growth of human osteosarcoma. PLoS One 5, e14182.